Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
about
Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.Comparative in vitro activity of SM7338, a new carbapenem antimicrobial agent.Management of listeriosis.In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticSusceptibility of enterococci and epidemiology of enterococcal infection in the 1980sAntibiotic combinations: should they be tested?Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.Pharmacokinetics and transplacental passage of imipenem during pregnancy.Screening and treatment of infections caused by resistant enterococci.Therapy of enterococcal infections.Antimicrobial therapy for the elderly patient.Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden.In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenesIn vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin.Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis.Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis.In vitro activity of imipenem--a review.Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.[N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
P2860
Q33745963-DD2F3777-88A5-4561-82CC-2CE62A2EFA61Q34519808-306378D4-EE1F-4007-A08F-51B13D7AE081Q35121133-C05CF01D-DDBE-4C1F-A177-47ECEB2802CCQ35342147-C0F4053D-C8DA-40F6-82A9-9E32EA836DB2Q35374228-D6737B58-AFB9-4311-80CE-BB557E21EEB8Q35570582-322583DF-50BD-49F6-BCDA-49FEA3AE9695Q36473436-8546F491-BCA5-4F8A-A78F-1869AA8D5271Q36632795-E846BBBA-3617-4F09-997C-F9952B5F4560Q36757804-1B798668-7187-431E-ABB2-E2CC653C51ACQ36758177-6F371A89-B8CF-4565-B3EB-9A1F97DD5602Q37711795-71414241-831D-44B8-9F29-5C07736420E6Q37909576-12E26D5E-4CE9-4598-981F-6D39DEF01FEFQ38006505-A427A41E-E8C3-4EA3-BEA0-03F7F684C519Q39465586-7A73748D-9FC3-4E97-9EAC-1FE9EE1274A1Q39485789-694EA301-D670-4F06-B2A8-DCC2749E78FDQ39818976-9150A4C5-86E0-4CA8-AF69-D333BDF1A4FFQ39834031-DB9F7171-E863-4F76-A3E2-713792BBD7B4Q39834431-50FBC971-702A-44A0-A61D-2E6ED634A8C3Q39835039-2FCF05CC-0B83-4718-BD2E-058CFD5B9E3DQ39849463-B39D2D1C-3C74-4C97-9ED2-B2888AE4822BQ39856621-A138B1C8-96DD-418B-AC83-CEDC2309F50EQ40192467-476E08CF-2895-427D-9F04-EC517B3A9336Q40447370-E5672D1C-9E1E-48E8-A04D-99480EBA3E14Q42727865-40E61151-63B6-44FC-8E86-EF36E1F1C4EBQ42926907-EF2F982A-19C9-4DDE-9669-A6A995032CA8Q44882404-93EC4E0B-83D0-4370-8089-1215714A8519
P2860
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Susceptibility of enterococci ...... nation with an aminoglycoside.
@en
Susceptibility of enterococci ...... nation with an aminoglycoside.
@nl
type
label
Susceptibility of enterococci ...... nation with an aminoglycoside.
@en
Susceptibility of enterococci ...... nation with an aminoglycoside.
@nl
prefLabel
Susceptibility of enterococci ...... nation with an aminoglycoside.
@en
Susceptibility of enterococci ...... nation with an aminoglycoside.
@nl
P2860
P356
P1476
Susceptibility of enterococci ...... nation with an aminoglycoside.
@en
P2093
G M Eliopoulos
R C Moellering
P2860
P304
P356
10.1128/AAC.19.5.789
P407
P577
1981-05-01T00:00:00Z